Cleveland Clinic revealed its predictions for the top 10 medical innovations of 2020 on Oct. 23, naming five cardiovascular concepts in the process.
A CV innovation didn’t take the number-one slot for next year’s anticipated heavyweights—that was a recently FDA-approved dual-acting osteoporosis drug known as romosozumab—but half of Cleveland Clinic’s predictions had to do with cardiology. A panel of physicians and researchers led by Michael Roizen, MD, emeritus chief wellness officer at Cleveland Clinic, ranked the up-and-coming tech.
Click here to read the complete article.
Story excerpt provided by Cardiovascular Business.
Written by Anicka Slachta.
Originally published October 29, 2019.